01 · THE CUSTOMER PROBLEM
Hydrogel teams must balance gelation, swelling, mechanics, release and degradation—variables that cannot be solved with a commodity polymer specification.
Mykito engineers both the chitosan molecule and the gel architecture to support topical, injectable or preformed systems.
Chitosan hydrogels combine high water content with a polymer network that can be chemically and mechanically tuned.
02 · RECOMMENDED STARTING POINT
Start with the material designed for the decision.
Mykito can engineer the chitosan specification, crosslinking route and formulation inputs needed to create injectable, topical or preformed hydrogels around the final application.
Without the shell
Controlled fungal sourcing supports a traceable, non-animal supply strategy.
Specification engineered
MW, DDA, purity, charge density and format are selected around the target result.
Application ready
Powder is only the starting point; Mykito also develops films, fibers, gels, coatings and formulations.
One technical partner
Material selection, formulation support and the validation plan are connected from the first sample.
03 · PERFORMANCE TARGETS
Build toward outcomes a buyer can measure.
Moisture management
Hydrated networks can absorb fluid while maintaining a conformable interface with tissue or a product surface.
Active encapsulation
Drugs, proteins, cells or complementary polymers can be incorporated within the gel matrix.
Controlled release
Crosslink density, degradation and polymer interactions provide multiple release-control mechanisms.
Regenerative matrices
Porous hydrated structures can support cell culture, scaffold and tissue-engineering research.
04 · GO / NO-GO CRITERIA
Define the evidence before testing begins.
The first program is designed around three decision-making outputs—not an open-ended material trial.
Gelation and process window
Swelling and mechanical profile
Release, degradation and application-specific compatibility
05 · FROM SAMPLE TO DECISION
A practical application program,
not a bag of powder.
Define
Agree on the function, baseline, constraints and measurable success criteria.
Screen
Select the MW, DDA, purity, dose and physical format that fit the application.
Validate
Test the winning system in the finished formulation, device, process or use environment.
Recommended first request: A hydrogel-grade screening set with target gelation and swelling ranges.
Start the Sample Brief06 · WHY CHITOSAN
Cationic complexation + matrix control
Protonated amino groups can interact with selected anionic actives, polymers and biological surfaces. MW, DDA, crosslinking and architecture then provide levers for adhesion, protection and release.
There is no universal concentration. Grade and dose are screened against pH, interacting ingredients, process conditions and the target performance profile.
Route-specific purity, residuals, compatibility, stability and regulatory suitability are established for the finished system.